The Cure Starts Now has funded $18,897,055 in pediatric brain cancer research in partnership with the DIPG / DMG Collaborative. This includes 119 grants at over 100 hospitals in 17 countries.




Funding of Pediatric Brain Tumor Consortium Foundation - $25,000

Amount
$25,000.00
Date

January 2021

International DIPG/DMG Registry And Repository - $1,508,198

Amount
$1,508,198.00
Date

December 2020

Children's Cancer Institute - $99,251

Amount
$99,251.00
Date

September 2020

Discovering New Epigenetic Players in DIPG Oncogenesis

Northwestern Memorial Hospital - $110,000

Amount
$110,000.00
Date

September 2020

Development of Histone Demethylase Inhibitor Against DIPG

The Hospital for Sick Children - $100,000

Amount
$100,000.00
Date

September 2020

Methionne Deptrivation as a Therapeutic Strategy for Diffuse Intrinsic Pontine Glioma

Hunter Medical Research Institute - $145,640

Amount
$145,640.00
Date

September 2020

Combatt DMG: Combined Anti-tumor Targeting of Diffuse Midline Gliomas

CONNECT Consortium - $489,801.26

Amount
$489,801.00
Date

September 2020

CONNECT (COllaborative Network for NEurooncology Clinical Trials) Consortium

International DIPG/DMG Registry And Repository - $862,671

Amount
$862,671.00
Date

May 2020

Funding of Pediatric Brain Tumor Consortium Foundation - $25,000

Amount
$25,000.00
Date

January 2020

Sydney Children's Hospital - $151,468

Amount
$151,468.00
Date

December 2019

Developing New Epigenetic Combination Treatments Against DIPG.

Oncoceutics ONC201 - $100,000

Amount
$100,000.00
Date

December 2019

Expansion of the ONC201 Compassionate Use.

University of Sydney - $100,000

Amount
$100,000.00
Date

November 2019

Targeting hypoxia and mitochondrial metabolism with repurposing drugs as an approach of radiosensitization for diffuse intrinsic pontine gliomas.

University of Michigan Hospitals - $157,856

Amount
$157,856.00
Date

November 2019

Therapeutic reversal of pre-natal pontine ID1 signaling in DIPG

Dayton Children's Hospital - $69,600

Amount
$69,600.00
Date

November 2019

Responses of distinct cell populations to PDGFRA inhibitors in diffuse intrinsic pontine glioma.

Institute of Cancer Research - $121,863

Amount
$121,863.00
Date

November 2019

Targeting Top3A-Amplified DIPG cells by Sirtuin inhibition.